HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of refractory complex-partial status epilepticus with propofol: case report.

AbstractPURPOSE:
We report a case of a 65-year-old woman who had a subarachnoid and intraventricular hemorrhage secondary to rupture of an anterior communicating artery aneurysm and developed nonconvulsive status epilepticus of the complex-partial type, refractory to phenytoin (PHT), phenobarbital (PB), valproate (VPA), and lorazepam (LZP).
METHODS:
Three weeks after diagnosis of nonconvulsive status epilepticus, general anesthesia was induced with propofol and titrated to burst suppression on the electroencephalogram (EEG).
RESULTS:
During propofol infusion, the serum VPA level declined markedly, and despite >3 g daily doses, did not return to the therapeutic range, until several days after propofol was discontinued. Continuous propofol infusion was stopped after 7 days, and the patient recovered consciousness. Despite further complications, she gradually regained normal function and was discharged home 4 months after surgery.
CONCLUSIONS:
This is the first case of nonconvulsive status epilepticus successfully treated with propofol.
AuthorsM Begemann, A J Rowan, S Tuhrim
JournalEpilepsia (Epilepsia) Vol. 41 Issue 1 Pg. 105-9 (Jan 2000) ISSN: 0013-9580 [Print] United States
PMID10643932 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anticonvulsants
  • Valproic Acid
  • Propofol
Topics
  • Aged
  • Anticonvulsants (blood, therapeutic use)
  • Drug Interactions
  • Drug Resistance, Multiple
  • Electroencephalography (drug effects)
  • Epilepsy, Complex Partial (blood, drug therapy, physiopathology)
  • Female
  • Humans
  • Propofol (blood, therapeutic use)
  • Status Epilepticus (blood, drug therapy, physiopathology)
  • Valproic Acid (blood, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: